Tonix Pharmaceuticals Holding Corp., which trades on the Nasdaq Global Market under the ticker symbol TNXP, maintains a prevailing share price of approximately $13.56. Stock valuations fluctuate continuously during open market trading sessions in response to clinical trial milestone announcements, regulatory updates from federal health authorities, secondary equity offerings, and biotech sector sentiment. Institutional investors and market analysts monitor these pricing movements closely to assess equity volatility and clinical development progress across its pharmaceutical pipeline.